REQUEST A DEMO
Total
USD $0.00
Search more companies

Realcan Pharmaceutical Group Co., Ltd (China)

Main Activities: Hospitals | Drugs and Druggists' Sundries Merchant Wholesalers | Computer Systems Design and Related Services
Full name: Realcan Pharmaceutical Group Co., Ltd Profile Updated: November 04, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Chinese Download a sample report

The Company was restructured into a stock company from Shandong Reeking Pharmaceutical Distribution Co., Ltd. initiated by Miss Zhang Renhua, Mr. Han Xu, TBNatureLimited and Qingdao Ruihua Pharmaceutical Strategy Consulting Services Ltd. The company is a high-growth, medium-sized pharmaceutical direct marketing services provider, with Shandong Province as its target market. It main business is direct marketing to large-scale hospitals and basic health care market which is complemented by commercial distribution. It is a pharmaceutical business enterprise with modern pharmaceutical logistics qualification and ability and modern means of management such as e-commerce.

Headquarters
326 Jichang Rd. Zhfou Dt. Yantai Shandong
Yantai; Shandong; Postal Code: 264004

Contact Details: Purchase the Realcan Pharmaceutical Group Co., Ltd report to view the information.

Website: http://www.realcan.cn

Basic Information
Total Employees:
Purchase the Realcan Pharmaceutical Group Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Realcan Pharmaceutical Group Co., Ltd report to view the information.
Registered Capital:
Purchase the Realcan Pharmaceutical Group Co., Ltd report to view the information.
Financial Auditors:
Purchase the Realcan Pharmaceutical Group Co., Ltd report to view the information.
Incorporation Date:
September 21, 2004
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
19.13%
Purchase this report to view the information.
12.46%
Purchase this report to view the information.
5%
Purchase this report to view the information.
3.38%
Purchase this report to view the information.
2.9%
Subsidiaries
Dongying Ruikang Drugs Distribution Co., Ltd.
100%
Qingdao Ruikang Drug Distribution Ltd.
100%
Shandong Ruixiang Medical Devices Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Realcan Pharmaceutical Group Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
9.73%
Total operating revenue
9.63%
Operating profit (EBIT)
-21.27%
Net Profit (Loss) for the Period
-24.47%
Total assets
7.17%
Total equity
5.23%
Operating Profit Margin (ROS)
-1.91%
Net Profit Margin
-1.58%
Return on Equity (ROE)
-3.12%
Debt to Equity Ratio
16.61%
Quick Ratio
0.04%
Cash Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?